Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C therapy in non-genotype 1 patients: the near future.

Journal of viral hepatitis - 1 Aug 2012

Wartelle-Bladou C, Le Folgoc G, Bourlière M, Lecomte L

Abstract excerpt

Worldwide, 50-70 million subjects are infected with an hepatitis C virus (HCV) genotype 2, 3, 4, 5 or 6. In these patients, the combination of PEG-INF-α and ribavirin remains the currently approved standard-of-care treatment. The identification of different potential therapeutic targets in the HCV life cycle has led to the development of both direct antiviral agents (DAAs) and reagents targeting host functions...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Clinical Trials as Topic
Share to Cyclophilins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Protease Inhibitors

Share to Ribavirin

Source

Identifiers

PMID: 22762136
DOI: 10.1111/j.1365-2893.2012.01634.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C therapy in non-genotype 1 patients: the near future.PMID 22762136Read ↗

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.Semantic proximity Read ↗

Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6.Semantic proximity Read ↗

Emerging therapies for hepatitis C virus.Semantic proximity Read ↗

New treatments for chronic hepatitis C virus infection.Semantic proximity Read ↗

Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C.Semantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues.Semantic proximity Read ↗

The hepatitis C revolution part 1: antiviral treatment options.Semantic proximity Read ↗

Current and Evolving Treatments of Genotype 1 Hepatitis C Virus.Semantic proximity Read ↗

Regimens for the Hepatitis C Treatment-Naive Patient.Semantic proximity Read ↗

Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?Semantic proximity Read ↗

Current and emerging therapeutic approaches to hepatitis C infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.